PatientsLikeMe : Kalawalla Treatment Report

You appear to have JavaScript disabled in your browser. PatientsLikeMe relies on JavaScript and Cookies to deliver the best possible experience to you. How do I enable JavaScript?

See More Treatments

See all treatments in the PatientsLikeMe system shared by patients just like you.

Patients

Taking Kalawalla
6 Patients currently take Kalawalla
2 Patients stopped taking Kalawalla
Valjo Sex: F Sensation: Moderate Overall: Mild Cognition: mild Vision: moderate Speech: none Swallowing: mild Upper limb: none Walking: moderate See profile Valjo 1600 mg daily since Sep 15, 2007
brewt1 Sex: M Sensation: None Overall: None Cognition: mild Vision: none Speech: mild Swallowing: mild Upper limb: mild Walking: moderate See profile brewt1 1600 mg daily since Mar 23, 2007

Kalawalla Treatment Report

What is Kalawalla? Kalawalla Polypodium leucotomos is a fern plant that contains cultivated Polypodium leucotomos extract, which grows exclusively in the Honduran jungles and rain forests. It is being used as a natural food supplement for Psoriasis, Vitiligo, Dermatitis & Multiple Sclerosis.

Jump to:: Reasons taken; Dosages; Duration; Patient Evaluations

Reasons taken

8 patients in the community are taking or have taken Kalawalla.

Reason	# Patients	Percentage of patients
Slow my MS progress	4	50%
Fatigue	1	12%
Bladder problems	1	12%
Other	1	12%

Other treatments patients are taking for Slow my MS progress include Glatiramer acetate, Interferon beta-1a IM Injection, and Interferon beta-1a SubQ injection.

Dosages

Based on the patients currently taking Kalawalla.

2 mL daily	4 tab(s) daily	800 mg daily	1600 mg daily
1	2	1	2

Duration

How long current patients have been taking Kalawalla or how long patients were taking Kalawalla before stopping.

Currently Taking Kalawalla

0-1 month	1-3 months	3-6 months	6 months-1year	1-2 years	2 years or more
0	0	1	3	1	0

Stopped Taking Kalawalla

0-1 month	1-3 months	3-6 months	6 months-1year	1-2 years	2 years or more
0	1	0	0	0	1

Why Patients Stopped Taking Kalawalla (multiple reasons could be selected)
Reason	# Patients	Percentage of patients
Doctor's advice	2	100%
Other	1	50%

Patient Reported Evaluations

Results from 1 patient evaluation. See the overall results and all individual evaluations.

Efficacy (Effect based on reason taken)

There is currently no efficacy data for Kalawalla.

Side-effects (as an overall problem)

Severe	0%	0
Moderate	0%	0
Mild	0%	0
None	100%	1

Top reported side-effects include:

Summary results are based on 1 individual response. For more information, see overall results for Adherence, Burden and Cost.

Individual Patient Reported Evaluations (1 of 1)

Valjo

Sex: F

Sensation: Moderate

Overall: Mild

Cognition: mild

Vision: moderate

Speech: none

Swallowing: mild

Upper limb: none

Walking: moderate

See profile
by Valjo
Sep 15, 2008